Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.4.6 (
urease
)
7,490
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The feasibility of a direct binding as well as competitive ELISA using
urease
labelled probe is described for buffalo pituitary
prolactin
. Rabbit anti-buPRL serum and goat anti-rabbit IgG conjugated to
urease
were used as primary and secondary antibodies respectively. Assay was performed in polystyrene wells pretreated with 3-amino-propyltriethoxysilane (APTES) compound. APTES pretreatment provided a more receptive surface for
prolactin
(
PRL
). In direct binding mode the assay could detect 24 pg of
PRL
per well. In competition mode the detection limit was less than 0.1 ng of competitor
PRL
per well. Urease-based ELISA was found highly sensitive when the substrate solution containing pH indicator, bromocresol purple, was used at lower pH (4-4.2). No false positive reactions occurred in the control wells. A good parallelism between buffalo serum sample inhibition curve and the standard
PRL
inhibition curve was observed.
...
PMID:A possible urease-based homologous ELISA for buffalo prolactin. 804 17